Growth factor delivery systems for the healing of wounds and...

Details Growth factor delivery systems for the healing of wounds and... Growth factor delivery systems for the healing of wounds and...

2007-01-30

2007-01-30

Davis, Ruth A (Department: 1651)

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Implant or insert

C424S040000, C424S422000, C424S427000, C424S484000

Reexamination Certificate

active

10340434

ABSTRACT:
The present invention features hydrogel drug delivery systems and methods of producing and using such systems for the treatment of wounds. The systems are based on a hydrogel into which a low concentration of growth factor, e.g., epidermal growth factor, is passively transferred from a dilute aqueous solution. When placed in contact with a wounded tissue, the growth factor passively transfers out of the contact lens to provide accelerated healing. The systems are applicable to ocular and other wound treatments.

REFERENCES:
patent: 4617299 (1986-10-01), Knepper
patent: 4668506 (1987-05-01), Bawa
patent: 4731244 (1988-03-01), Talle et al.
patent: 4923467 (1990-05-01), Thompson
patent: 4931279 (1990-06-01), Bawa et al.
patent: 4939135 (1990-07-01), Robertson et al.
patent: 4973466 (1990-11-01), Reich
patent: 4981841 (1991-01-01), Gibson
patent: 4983580 (1991-01-01), Gibson
patent: 5053388 (1991-10-01), Gibson et al.
patent: 5104408 (1992-04-01), Thompson
patent: 5124155 (1992-06-01), Reich
patent: 5124392 (1992-06-01), Robertson et al.
patent: 5156622 (1992-10-01), Thompson
patent: 5171318 (1992-12-01), Gibson et al.
patent: 5196027 (1993-03-01), Thompson et al.
patent: 5212168 (1993-05-01), Schwartz
patent: 5271939 (1993-12-01), Robertson et al.
patent: 5358706 (1994-10-01), Marlin et al.
patent: 5360611 (1994-11-01), Robertson et al.
patent: 5401509 (1995-03-01), Robertson et al.
patent: 5401510 (1995-03-01), Robertson et al.
patent: 5433745 (1995-07-01), Graham et al.
patent: 5472703 (1995-12-01), Vanderlaan et al.
patent: 5525349 (1996-06-01), Robertson et al.
patent: 5550188 (1996-08-01), Rhee et al.
patent: 5565519 (1996-10-01), Rhee et al.
patent: 5573775 (1996-11-01), Robertson et al.
patent: 5580570 (1996-12-01), Robertson et al.
patent: 5582835 (1996-12-01), Robertson et al.
patent: 5589184 (1996-12-01), Robertson et al.
patent: 5589185 (1996-12-01), Robertson et al.
patent: 5597381 (1997-01-01), Rizzo, III
patent: 5607688 (1997-03-01), Cejkova et al.
patent: 5616502 (1997-04-01), Haugland et al.
patent: 5665373 (1997-09-01), Robertson et al.
patent: 5695509 (1997-12-01), El Hage
patent: 5723131 (1998-03-01), Schultz et al.
patent: 5767079 (1998-06-01), Glaser et al.
patent: 5811446 (1998-09-01), Thomas
patent: 5836313 (1998-11-01), Perez et al.
patent: 5932205 (1999-08-01), Wang et al.
patent: 5942487 (1999-08-01), Ogawa et al.
patent: 5973089 (1999-10-01), Meijs et al.
patent: 6063116 (2000-05-01), Kelleher
patent: 6124273 (2000-09-01), Drohan et al.
patent: 6143315 (2000-11-01), Wang et al.
patent: 6201065 (2001-03-01), Pathak et al.
patent: 6201164 (2001-03-01), Wulff et al.
patent: 6248715 (2001-06-01), Rosenberg et al.
patent: 6261545 (2001-07-01), Okamoto
patent: 6268341 (2001-07-01), Rosenberg et al.
patent: 6331309 (2001-12-01), Jennings, Jr. et al.
patent: 6410045 (2002-06-01), Schultz et al.
patent: 2001/0046518 (2001-11-01), Sawhney
patent: 0 782 016 (1997-07-01), None
patent: 0 958 831 (1999-11-01), None
Hillman. “Management of acute glaucoma with pilocarpine-soaked hydrophilic lens”Br. J. Ophthal.,58: 674-679 (1974).
Wilson et al. “The Fas-Fas Ligand System and Other Modulators of Apoptosis in the Cornea”Investigative Ophthalmology and Visual Sciences, 37(8): 1582-92 (1996).
Lohmann et al. “Screening of Myopic Lasik Patients with Aggressive Woundhealing: Quantitative Determination of EGF mRNA in Corneal Epithelial Cells” 97thAnnual Meeting German Ophthalmological Society, K180 Berling Sep. 23-26, 1999.
Dua and Azuara-Blanco, “Amniotic Membrane Transplantation,”Br. J. Ophthalmol.83(6):748-752 (1999).
Wang et al., “Reduction in Corneal Haze and Apoptosis by Amniotic Membrane Matrix in Excimer Laser Photoablation in Rabbits,”J. Catract Refract. Surg.27(2):310-319 (2001).
Woo et al., “Effects of Amniotic Membrane on Epithelial Wound Healing and Stromal Remodelliing After Excimer Laser Keratectomy in Rabbit Cornea,”Br. J. Ophthalmol.85(3):345-349 (2001).
European Search Report for EP03719865.
European Search Report for EP03719865, Aug. 4, 2005.

Affiliated with

Also associated with

Rating

Growth factor delivery systems for the healing of wounds and... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Growth factor delivery systems for the healing of wounds and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Growth factor delivery systems for the healing of wounds and... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3749156